Company intelligence / Profile preview

PlasmaGen BioSciences

Bengaluru (Bangalore), Karnataka, Indiaplasmagen.com ↗

Ownership: Private
Employees: ~359
Development stage: Commercial

Overview

The company has completed stability tests for its two flagship products, Albumin and IVIG, and has other plasma protein products in the pipeline that are in the technology development phase[5]. Commercial operations commenced in December 2023[5].

Therapeutic areas: Hematology
Modalities: Plasma-derived therapeutic proteins
Industry: Biotech

Drug pipeline

2 assets

albumin

Commercial

Indications: Critical care

1 more asset in the full pipeline.

Request access →

Partnerships

Strategic partners for production[3]

Beyond the preview

Go deeper on PlasmaGen BioSciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PlasmaGen BioSciences.

Explore the full profile